Articles

Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.

Value investing is dead because passive investing has broken market structures, says hedge-fund legend David Einhorn.

Chili’s recently changed its menu design to try to prevent customers from ordering the starter as a main dish.

The economy is still booming by many measures — such as gross domestic product, job creation and unemployment — but Americans still aren’t all that happy.

While the cannabis business remains volatile, more educational programs are being launched as state-legal marijuana programs gear up.

While regional-bank stocks continue to be dragged down by the troubles assailing New York Community Bank, their bonds are holding up, suggesting bondholders view NYCB’s issues as isolated.

Three in 10 full-time workers now have hybrid schedules and another 12% are fully remote.

Shares of Ralph Lauren Corp. soared Thursday to the highest prices seen in nine years after the luxury lifestyle-products company delivered a big fiscal third-quarter profit beat amid strong holiday sales and a jump in direct-to-consumer sales.

The 30-year mortgage rate is averaging at 6.64%, Freddie Mac said in its latest weekly survey on Thursday.

A reader filed the right forms, but never got the refund they were expecting and now can’t get any answers

Making money by investing in pharmaceutical companies isn’t as easy as you might think.

Shares of Kellanova, formerly known as Kellogg, climbed Thursday as the snacks and cereal company, whose brands include Pop-Tarts, Cheez-It and Special K, beat fourth-quarter profit expectations, with price increases offsetting a decline in volume.